The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia
Open accessAbstract
N-methyl-D-aspartate receptors (NMDARs) represent a subclass of glutamate receptors that play a critical role in neuronal development and physiology. We report here the generation of mice expressing only 5% of normal levels of the essential NMDAR1 (NR1) subunit. Unlike NR1 null mice, these mice survive to adulthood and display behavioral abnormalities, including increased motor activity and stereotypy and deficits in social and sexual interactions. These behavioral alterations are similar to those observed in pharmacologically induced animal models of schizophrenia and can be ameliorated by treatment with haloperidol or clozapine, antipsychotic drugs that antagonize dopaminergic and serotonergic receptors. These findings support a model in which reduced NMDA receptor activity results in schizophrenic-like behavior and reveals how pharmacological manipulation of monoaminergic pathways can affect this phenotype.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Observational findings in some of these behavioral domains have been reported in some targeted gene mutations, e.g.deficits in social interaction within the home cage have been reported for mice deficient in the dishevelled-1 gene (Lijam et al. 1997) or the NMDA NR1 subunit (Mohn et al. 1999).”
From Sociability and preference for social novelty in five inbred strains: an approach to assess autistic‐like behavior in mice (2004) · cites this paper as Mohn et al. 1999
In the citing paper
“In supporting of this notion, NMDAR antagonism during an equivalent period in rodents (first 2 post-natal weeks) induces long-lasting behavioural and cognitive disturbances that are relevant to the schizophrenia phenotype and which extend into adolescence and adulthood 10,27 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [27]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Heteromeric NMDA receptors: molecular and functional distinction of subtypes
Monyer, H., Sprengel, R., Schoepfer, R., Herb, A., Higuchi, M., Lomeli, H., Burnashev, N., Sakmann, B., & Seeburg, P. H. (1992) · Science · doi:10.1126/science.256.5060.1217 · Cited by 2,541
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Self-citationAntipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Crawley, J. N., Belknap, J. K., Collins, A. C., Crabbe, J. C., Frankel, W. N., Henderson, N. D., HITZEMANN, R. J., Maxson, S. C., Miner, L. L., Silva, A. J., et al. (1997) · Psychopharmacology · doi:10.1007/s002130050327 · Cited by 1,372
Molecular diversity of the NMDA receptor channel
Kutsuwada, T., Kashiwabuchi, N., Mori, H., Sakimura, K., Kushiya, E., Araki, K., Meguro, H., Hisashi, M., Kumanishi, T., Arakawa, M., et al. (1992) · Nature · doi:10.1038/358036a0 · Cited by 1,352
HPRT-deficient (Lesch–Nyhan) mouse embryos derived from germline colonization by cultured cells
Hooper, M., Hardy, K., Handyside, A. H., Hunter, S., & Monk, M. (1987) · Nature · doi:10.1038/326292a0 · Cited by 1,218
Carlsson, M. L., & Carlsson, A. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90108-m · Cited by 1,086
Research works printed but not linked: 2
- Ereshefsky, 1989, Clozapine, Clin. Pharm., 8, 691
- Rosenbauer, 1980, Studies concerning the formation of vaginal plug in laboratory animals and its suitability for demonstrating the ultrastructure of spermatazoa, Folia Morphol. (Praha), 28, 126
Cited by
Sorted by citations
Items 501–600 of 1,000
Treadmill exercise enhances NMDA receptor expression in schizophrenia mice
Park, J.-K., Lee, S., & Kim, T. (2014) · Journal of Exercise Rehabilitation · doi:10.12965/jer.140088 · Cited by 35
TRP's: Links to schizophrenia?
Chahl, L. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2007.05.003 · Cited by 35
Sensorimotor Gating Deficits in Transgenic Mice Expressing a Constitutively Active Form of Gsα
Gould, T. J., Bizily, S. P., Tokarczyk, J., Kelly, M. P., Siegel, S. J., Kanes, S., & Abel, T. G. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300309 · Cited by 35
Kirby, B. P., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.09.010 · Cited by 36
Ju, P., & Cui, D. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmv135 · Cited by 33
The Role of the N-Methyl-D-Aspartate Receptors in Social Behavior in Rodents
Zoicas, I., & Kornhuber, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225599 · Cited by 35
Imaging Phenotypes and Genotypes in Schizophrenia
Turner, J. A., Smyth, P., Macciardi, F. M., Fallon, J. H., Kennedy, J. L., & Potkin, S. G. (2006) · Neuroinformatics · doi:10.1385/ni:4:1:21 · Cited by 36
Brody, S. A., Nakanishi, N., Tu, S., Lipton, S. A., & Geyer, M. A. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.024 · Cited by 34
GLT‐1 expression and Glu uptake in rat cerebral cortex are increased by phencyclidine
Fattorini, G., Melone, M., Bragina, L., Candiracci, C., Cozzi, A., Pellegrini-Giampietro, D. E., Torres-Ramos, M., Pérez‐Samartín, A., Matute, C., & Conti, F. (2008) · Glia · doi:10.1002/glia.20700 · Cited by 33
Javanbakht, A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.03.054 · Cited by 38
Presti-Torres, J., de Lima, M. N., Scalco, F. S., Caldana, F., Garcia, V. A., Guimarães, M. R., Schwartsmann, G., Roesler, R., & Schröder, N. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.09.020 · Cited by 35
Young receptors make smart mice
Bliss, T. (1999) · Nature · doi:10.1038/43333 · Cited by 34
Inta, D., Vogt, M. A., Elkin, H., Weber, T., Lima‐Ojeda, J. M., Schneider, M., Luoni, A., Riva, M. A., Gertz, K. R., Hellmann‐Regen, J., et al. (2013) · Hippocampus · doi:10.1002/hipo.22236 · Cited by 33
Kiselycznyk, C., Svenningsson, P., Delpire, E. J., & Holmes, A. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.015 · Cited by 33
Behavioral Phenotypes for Negative Symptoms in Animal Models of Schizophrenia
Miyamoto, Y., & Nitta, A. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14r02cr · Cited by 32
Annual Research Review: Transgenic mouse models of childhood‐onset psychiatric disorders
Robertson, H. R., & Feng, G. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02380.x · Cited by 33
Genome-wide association mapping of loci for antipsychotic-induced extrapyramidal symptoms in mice
Crowley, J. J., Kim, Y., Szatkiewicz, J., Pratt, A. L., Quackenbush, C. R., Adkins, D. E., van den Oord, E. J. C. G., Bogue, M. A., Yang, H., Wang, W. W., et al. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9385-8 · Cited by 33
Monoclonal antibodies from a patient with anti‐ NMDA receptor encephalitis
Sharma, R., Al‐Saleem, F. H., Panzer, J. A., Lee, J., Puligedda, R. D., Felicori, L. F., Kattala, C. D., Rattelle, A., Ippolito, G. C., Cox, R. H., et al. (2018) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.592 · Cited by 33
Disease-associated GRIN protein truncating variants trigger NMDA receptor loss-of-function
Santos‐Gómez, A., Míguez‐Cabello, F., García‐Recio, A., Locubiche, S., García-Díaz, R., Insuga, V. M. S., Guerrero, R., Juliá‐Palacios, N., Ciruela, F., García‐Cazorla, À., et al. (2020) · Human Molecular Genetics · doi:10.1093/hmg/ddaa220 · Cited by 35
Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain
Tarazi, F. I., Choi, Y. K., Gardner, M., Wong, E. H. F., Henry, B., & Shahid, M. (2009) · Synapse · doi:10.1002/syn.20618 · Cited by 33
Galehdari, H. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9148-5 · Cited by 33
Nam, D., Adams, D. H., Flewelling, L. J., & Basu, N. (2010) · Aquatic Toxicology · doi:10.1016/j.aquatox.2010.05.014 · Cited by 33
Maslinic acid ameliorates NMDA receptor blockade-induced schizophrenia-like behaviors in mice
Jeon, S. J., Kim, E., Lee, J. S., Oh, H. K., Zhang, J., Kwon, Y., Jang, D. S., & Ryu, J. H. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.014 · Cited by 33
Segev, A., Yanagi, M., Scott, D. E., Southcott, S. A., Lister, J. M., Tan, C., Li, W., Birnbaum, S. G., Kourrich, S., & Tamminga, C. A. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0124-3 · Cited by 34
Schizophrenia: an integrative approach to modelling a complex disorder
Robertson, G. S., Hori, S. E., & Powell, K. J. (2006) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0619 · Cited by 34
Piato, Â., Benvenutti, R., Gallas‐Lopes, M., Marcon, M., Reschke, C. R., & Herrmann, A. P. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210215121428 · Cited by 35
GABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes
Yu, Z., Fang, Q., Xiao, X., Wang, Y., Cai, Y.-Q., Cao, H., Hu, G., Chen, Z., Fei, J., Gong, N., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069883 · Cited by 34
TRP Channels and Psychiatric Disorders
Chahl, L. A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_51 · Cited by 32
Regulation of NMDA Receptors by Kinases and Phosphatases
Salter, M. W., Dong, Y., Kalia, L. V., Liu, X. J., & Pitcher, G. M. (2009) · Europe PMC (PubMed Central) · Cited by 32
Deng, X., Sagata, N., Takeuchi, N., Tanaka, M., Ninomiya, H., Iwata, N., Ozaki, N., Shibata, H., & Fukumaki, Y. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-58 · Cited by 32
Genetic and genomic approaches to reward and addiction
Mohn, A. R., Yao, W., & Caron, M. G. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.025 · Cited by 32
Self-citationNinan, I., & Wang, R. Y. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02549.x · Cited by 32
Martucci, L., Wong, A. H. C., Trakalo, J., Cate‐Carter, T., Wong, G. W. H., Macciardi, F. M., & Kennedy, J. L. (2003) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.20014 · Cited by 33
Maia‐de‐Oliveira, J. P., Soares, B. L., Ramalho, T. E. B., Gavioli, E. C., Soares-Rachetti, V. D. P., Teixeira, L., Baker, G. B., Dursun, S. M., & Hallak, J. E. C. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2014.12.035 · Cited by 33
Bygrave, A. M., Kilonzo, K., Kullmann, D. M., Bannerman, D. M., & Kätzel, D. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00835 · Cited by 35
Turic, D., Langley, K., Williams, H. J., Norton, N., Williams, N. M., Moskvina, V., van den Bree, M. B. M., Owen, M. J., Thapar, A., & O’Donovan, M. C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.025 · Cited by 31
Kumar, K., Patro, N., & Patro, I. K. (2013) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-013-9942-7 · Cited by 31
Metabotropic Glutamate Receptors: Potential Drug Targets for Psychiatric Disorders
Yasuhara, A., & Chaki, S. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004020020 · Cited by 32
GluN1 hypomorph mice exhibit wide‐ranging behavioral alterations
Barkus, C., Dawson, L. A., Sharp, T., & Bannerman, D. M. (2012) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2012.00767.x · Cited by 31
Mutation screening of GRIN2B in schizophrenia and autism spectrum disorder in a Japanese population
Takasaki, Y., Koide, T., Wang, C., Kimura, H., Xing, J., Kushima, I., Ishizuka, K., Mori, D., Sekiguchi, M., Ikeda, M., et al. (2016) · Scientific Reports · doi:10.1038/srep33311 · Cited by 29
Developing zebrafish experimental animal models relevant to schizophrenia
Demin, K. A., Мешалкина, Д. А., Volgin, A. D., Yakovlev, O. V., de Abreu, M. S., Alekseeva, P. A., Friend, A. J., Lakstygal, A. M., Zabegalov, K. N., Amstislavskaya, T. G., et al. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.017 · Cited by 30
Umemori, J., Takao, K., Koshimizu, H., Hattori, S., Furuse, T., Wakana, S., & Miyakawa, T. (2013) · BMC Research Notes · doi:10.1186/1756-0500-6-203 · Cited by 32
Prenatal lipopolysaccharide treatment enhances MK-801-induced psychotomimetic effects in rats
Basta‐Kaim, A., Fijał, K., Budziszewska, B., Regulska, M., Leśkiewicz, M., Kubera, M., Gołembiowska, K., Lasoń, W., & Wędzony, K. (2011) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.12.026 · Cited by 30
Pathophysiology and Animal Models of Schizophrenia
Dawe, G. S., Hwang, E. H. J., & Tan, C. H. (2009) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v38n5p425 · Cited by 32
Kassan, A., Egawa, J., Zhang, Z., Almenar‐Queralt, A., Nguyen, Q. M., Lajevardi, Y., Kim, K., Posadas, E., Jeste, D. V., Roth, D. M., et al. (2016) · Journal of Neurophysiology · doi:10.1152/jn.00481.2016 · Cited by 29
Lee, J. H., Zhang, J. Y., Wei, Z. Z., & Yu, S. P. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.02.015 · Cited by 30
Neurobiology and treatment of social cognition in schizophrenia: Bridging the bed-bench gap
Kimoto, S., Makinodan, M., & Kishimoto, T. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.10.022 · Cited by 33
Cytogenetics and gene discovery in psychiatric disorders
Pickard, B. S., Millar, J. K., Porteous, D. J., Muir, W. J., & Blackwood, D. (2005) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500293 · Cited by 29
Pal, R., Aǵbaş, A., Bao, X., Hui, D., Leary, C. B., Hunt, J., Naniwadekar, A. S., Michaelis, M. L., Kumar, K. N., & Michaelis, E. K. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.046 · Cited by 31
Fujimura, M., Hashimoto, K., & Yamagami, K. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00235-1 · Cited by 30
Nanobody therapy rescues behavioural deficits of NMDA receptor hypofunction
Oosterlaken, M., Rogliardo, A., Lipina, T. V., Lafon, P., Tsitokana, M. E., Keck, M., Cahuzac, H., Prieu-Sérandon, P., Diem, S., Derieux, C., et al. (2025) · Nature · doi:10.1038/s41586-025-09265-8 · Cited by 31
Liu, W., Wang, X., Zhang, R., & Zhou, Y. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.04.021 · Cited by 29
Clozapine does not require 5-HT1A receptors to block the locomotor hyperactivity induced by MK-801
Scorza, M. C., Castañé, A., Bortolozzi, A. A., & Artigas, F. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.04.012 · Cited by 29
Locomotor activity correlates with modifications of hippocampal mossy fibre synaptic transmission
Kobayashi, K., Ikeda, Y., & Suzuki, H. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.05079.x · Cited by 29
Wang, D., Noda, Y., Tsunekawa, H., Zhou, Y., Miyazaki, M., Senzaki, K., Nitta, A., & Nabeshima, T. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.124685 · Cited by 29
Makino, C., Shibata, H., Ninomiya, H., Tashiro, N., & Fukumaki, Y. (2005) · Psychiatric Genetics · doi:10.1097/00041444-200509000-00014 · Cited by 29
Phenotypic characterization of a new Grin1 mutant mouse generated by ENU mutagenesis
Furuse, T., Wada, Y., Hattori, K., Yamada, I., Kushida, T., Shibukawa, Y., Masuya, H., Kaneda, H., Miura, I., Seno, N., et al. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07164.x · Cited by 29
Schotanus, S. M., Fredholm, B. B., & Chergui, K. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.03.025 · Cited by 29
Gliotransmission at central glutamatergic synapses: d-serine on stage
Martineau, M., Baux, G., & Mothet, J. (2006) · Journal of Physiology-Paris · doi:10.1016/j.jphysparis.2005.12.011 · Cited by 29
GRIN1 locus may modify the susceptibility to seizures during alcohol withdrawal
Rujescu, D., Soyka, M., Dahmen, N., Preuss, U. W., Hartmann, A. M., Giegling, I., Koller, G., Bondy, B., Möller, H. ‐., & Szegedi, A. (2005) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30112 · Cited by 29
Inta, D., Filipović, D., Lima‐Ojeda, J. M., Dormann, C., Pfeiffer, N., Gasparini, F., & Gass, P. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.12.035 · Cited by 28
Kruk-Słomka, M., Budzyńska, B., Słomka, T., Banaszkiewicz, I., & Biała, G. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9662-0 · Cited by 28
Ketamine Self-Administration Reduces the Homeostasis of the Glutamate Synapse in the Rat Brain
Caffino, L., Piva, A., Giannotti, G., Chio, M. D., Mottarlini, F., Vènniro, M., Yew, D. T. W., Chiamulera, C., & Fumagalli, F. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0231-6 · Cited by 28
Loureiro, C. M., Shuhama, R., Fachim, H., Menezes, P. R., Del‐Ben, C. M., & Louzada‐Júnior, P. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.06.037 · Cited by 28
Progressive neuroanatomical changes caused by Grin1 loss-of-function mutation
Intson, K., van Eede, M. C., Islam, R., Milenkovic, M., Yan, Y., Salahpour, A., Henkelman, R. M., & Ramsey, A. J. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104527 · Cited by 28
Neuronal Plasticity: Neuronal Organization is Associated with Neurological Disorders
Dhuriya, Y. K., & Sharma, D. (2020) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01555-2 · Cited by 31
Hattori, Y., Matsumoto, S., Morimoto, S., Daini, M., Toyofuku, M., Matsuda, S., Baba, R., Murakami, K., Iwatani, M., Oki, H., et al. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114522 · Cited by 30
Christie, L. A., Russell, T. A., Xu, J., Wood, L., Shepherd, G. M., & Contractor, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908206107 · Cited by 28
Ohtsuki, T., Toru, M., & Arinami, T. (2001) · Psychiatric Genetics · doi:10.1097/00041444-200106000-00004 · Cited by 28
MicroRNAs suggest a new mechanism for altered brain gene expression in schizophrenia
Coyle, J. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813321106 · Cited by 28
Chen, P. E., Errington, M. L., Kneussel, M., Chen, G., Annala, A. J., Rudhard, Y., Rast, G. F., Specht, C. G., Tigaret, C. M., Nassar, M. A., et al. (2009) · Learning & Memory · doi:10.1101/lm.1316909 · Cited by 28
Jiang, H., Jiang, W., Zou, J., Wang, B., Yu, M., Pan, Y., Lin, Y., Mao, Y., & Wang, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.03.031 · Cited by 27
Dong, B., Yang, Y., Han, D., & Wang, Y. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1174738 · Cited by 30
Treen, D., Vila, S., Mollà, L., Forcadell, E., Chamorro, J., Bulbena, A., & Pérez, V. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.01.005 · Cited by 29
Autoimmune Aspects of Neurodegenerative and Psychiatric Diseases: A Template for Innovative Therapy
de Haan, P., Klein, H. C., & Hart, B. A. ‘. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00046 · Cited by 27
Kruk-Słomka, M., Banaszkiewicz, I., Słomka, T., & Biała, G. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1596-0 · Cited by 26
Preweaning Sensorimotor Deficits and Adolescent Hypersociability in Grin1 Knockdown Mice
Moy, S. S., Nikolova, V. D., Riddick, N. V., Baker, L. K., & Koller, B. H. (2012) · Developmental Neuroscience · doi:10.1159/000337984 · Cited by 28
Self-citationKoronyo‐Hamaoui, M., Frisch, A., STEIN, D., DENZIGER, Y., Leor, S., Michaelovsky, E., Laufer, N., Carel, C. A., Fennig, S., & Mimouni, M. (2005) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2005.07.010 · Cited by 26
Assessments of Cognitive Deficits in Mutant Mice
Rodriguiz, R. M., & Wetsel, W. C. (2006) · Frontiers in neuroscience · doi:10.1201/9781420004335.ch12 · Cited by 27
Han, L., Picker, J. D., Schaevitz, L. R., Tsai, G. E., Feng, J., Jiang, Z., Chu, H. C., Basu, A. C., Berger-Sweeney, J. E., & Coyle, J. T. (2009) · Synapse · doi:10.1002/syn.20649 · Cited by 27
Miyamoto, S., Snouwaert, J., Koller, B., Moy, S., Lieberman, J., & Duncan, G. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300548 · Cited by 27
Self-citationGenetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity
Shnayder, N. A., Novitsky, M. A., Незнанов, Н. Г., Васильевич, Л. О., Asadullin, A. R., Petrov, A. V., Дмитренко, Д. В., Narodova, E. A., Popenko, N. V., & Nasyrova, R. F. (2022) · Genes · doi:10.3390/genes13030457 · Cited by 28
5-HT6 Receptor Ligands and their Antipsychotic Potential
Arnt, J., & Olsen, C. K. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-385902-0.00006-1 · Cited by 26
Saito, Y., Tsuzuki, K., Yamada, N., Okado, H., Miwa, A., Goto, F., & Ozawa, S. (2003) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00548-x · Cited by 26
Adult forebrain NMDA receptors gate social motivation and social memory
Jacobs, S., & Tsien, J. Z. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.08.019 · Cited by 26
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice
Kruk-Słomka, M., Banaszkiewicz, I., & Biała, G. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9702-4 · Cited by 26
In Vitro and In Vivo Models for the Investigation of Potential Drugs Against Schizophrenia
Koszła, O., Targowska‐Duda, K. M., Kędzierska, E., & Kaczor, A. A. (2020) · Biomolecules · doi:10.3390/biom10010160 · Cited by 26
Allosteric modulation of neurotransmitter transporters at excitatory synapses
Vandenberg, R. J., Ju, P., Aubrey, K. R., Ryan, R. M., & Mitrovic, A. D. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.05.006 · Cited by 26
Torres, G., Hallas, B. H., Vernace, V. A., Jones, C., Gross, K. W., & Horowitz, J. M. (2003) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2003.09.020 · Cited by 26
Barbon, A., Fumagalli, F., Via, L. L., Caracciolo, L., Racagni, G., Riva, M. A., & Barlati, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.009 · Cited by 26
Schmitt, A., Fendt, M., Zink, M., Ebert, U., Starke, M., Berthold, M., Herb, A., Petroianu, G. A., Falkai, P., & Henn, F. A. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0440-7 · Cited by 26
Advances in the Treatment of Cognitive Impairment in Schizophrenia: Targeting NMDA Receptor Pathways
Zhang, T., Liu, C., Zhong, N., Wang, Y., Huang, Y., & Zhang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910668 · Cited by 26
Distorted neurocomputation by a small number of extra-large spines in psychiatric disorders
Obi-Nagata, K., Suzuki, N., Miyake, R., MacDonald, M. L., Fish, K. N., Ozawa, K., Nagahama, K., Okimura, T., Tanaka, S., Kano, M., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade5973 · Cited by 30
Marek, G. J. (2007) · International review of neurobiology · doi:10.1016/s0074-7742(06)78006-0 · Cited by 25
Motawaj, M., & Arrang, J. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07618.x · Cited by 25
Mouse Molecular Genetic Technologies
Tecott, L. H. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.11.995 · Cited by 25
Rudhard, Y., Kneussel, M., Nassar, M. A., Rast, G. F., Annala, A. J., Chen, P. E., Tigaret, C. M., Dean, I., Roes, J., Gibb, A. J., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02323.2003 · Cited by 25
Prolonged Ketamine Effects in Sp4 Hypomorphic Mice: Mimicking Phenotypes of Schizophrenia
Ji, B., Wang, X., Pinto‐Duarte, A., Kim, M., Caldwell, S., Young, J. W., Behrens, M. M., B, T. J. S. A., Geyer, M. A., & Zhou, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066327 · Cited by 24
Differential effects of NMDA receptor antagonism on spine density
Ruddy, R. M., Chen, Y., Milenkovic, M., & Ramsey, A. J. (2014) · Synapse · doi:10.1002/syn.21784 · Cited by 23
Spano, M. S., Fattore, L., Cadeddu, F., Fratta, W., & Fadda, P. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2839-1 · Cited by 24
Metadata
- Authors
- Mohn, A. R., Gainetdinov, R. R., Caron, M. G., & Koller, B. H.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Koller, Beverly H
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 98
- Issue
- 4
- Pages
- 427-436
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2164674870
- Cited by
- 1,075
- References
- 64
- Citations by year
- 2026: 13 · 2025: 14 · 2024: 19 · 2023: 17 · 2022: 28 · 2021: 26 · 2020: 26 · 2019: 28 · 2018: 29 · 2017: 27 · 2016: 46 · 2015: 40 · 2014: 39 · 2013: 42 · 2012: 45
- FWCI
- 24.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of General Medical Sciences (T32GM007092, T32 GM07092)
- National Institute of Neurological Disorders and Stroke (NS-19576, R01NS019576)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- NMDA receptor, NR1 subunit, schizophrenia, mouse model, motor activity, stereotypy, social interaction deficits, antipsychotic drugs, haloperidol, clozapine, monoaminergic pathways, glutamate receptors
- MeSH terms
- Animals, Antisocial Personality Disorder, Behavior, Animal, Clozapine, Disease Models, Animal, Female, Haloperidol, Male, Motor Activity, Phencyclidine, Schizophrenic Psychology, Serotonin Antagonists, Sexual Behavior, Animal, Social Behavior, Stereotyped Behavior, Antipsychotic Agents, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Mice, Knockout, Dopamine Antagonists, Excitatory Amino Acid Antagonists, Glutamic Acid, Calcium Signaling, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review